Aducanumab Filed In Japan Despite Recent US Setback

Large Market Awaits If Approved

 
• By Ian Haydock
  
Alzheimers_Cells
Japan Filing For Aducanumab In Alzheimer's • Source: Shutterstock

More from Japan

More from Focus On Asia